The Gamble lab uses epidemiologic methods to address clinically important and applied research questions in the space of drug safety and effectiveness primarily through knowledge syntheses and observational drug studies. Other research interests of the lab include knowledge translation of drug information, quantitative benefit-risk analysis, drug-induced disease, and pharmaceutical policy evaluation.The lab's primary therapeuetic area of interest is diabetes. 

We are thankful for those who have supported our research including the Canadian Institute for Health Research, Canadian Foundation for Innovation, Diabetes Canada, Heart and Stroke Foundation of Canada, NL Centre for Applied Health Research, NL Research and Development Corporation.